These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 6137556)

  • 1. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.
    Montoya GA; Molgó J; Lemeignan M; Lechat P
    Acta Physiol Pharmacol Latinoam; 1984; 34(4):409-18. PubMed ID: 6242265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitatory effects of 4-aminopyridine on normal neuromuscular transmission.
    Kim YI; Goldner MM; Sanders DB
    Muscle Nerve; 1980; 3(2):105-11. PubMed ID: 6245354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification by lithium of transmitter release at the neuromuscular junction of the frog.
    Branisteanu DD; Volle RL
    J Pharmacol Exp Ther; 1975 Aug; 194(2):362-72. PubMed ID: 239225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of lead on neuromuscular junctions.
    Atchison WD; Narahashi T
    Neurotoxicology; 1984; 5(3):267-82. PubMed ID: 6097847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 4-aminopyridine at the frog neuromuscular junction.
    Molgo J; Lemeignan M; Lechat P
    J Pharmacol Exp Ther; 1977 Dec; 203(3):653-63. PubMed ID: 21957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylmercury-induced depression of neuromuscular transmission in the rat.
    Atchison WD; Narahashi T
    Neurotoxicology; 1982 Nov; 3(3):37-50. PubMed ID: 6298679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of K+-channel blockers on transmitter release in bullfrog sympathetic ganglia.
    Kumamoto E; Kuba K
    J Pharmacol Exp Ther; 1985 Oct; 235(1):241-7. PubMed ID: 2413197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Presynaptic effects of aminopyridines on the neuromuscular junction of vertebrates].
    Molgó J; Lemeignan M; Peradejordi F; Lechat P
    J Pharmacol; 1985; 16 Suppl 2():109-44. PubMed ID: 2417060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycosides and 3,4-diaminopyridine on neuromuscular block caused by botulinum type A toxin.
    Molgó J; Lemeignan M; Thesleff S
    Muscle Nerve; 1987 Jun; 10(5):464-70. PubMed ID: 3497343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The action of thallium acetate on phasic transmitter release in the mouse neuromuscular junction.
    Wiegand H; Lohmann H; Chandra SV
    Arch Toxicol; 1986 Apr; 58(4):265-70. PubMed ID: 2424403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Ca2+ channel blocker neurotoxins on transmitter release and presynaptic currents at the mouse neuromuscular junction.
    Katz E; Protti DA; Ferro PA; Rosato Siri MD; Uchitel OD
    Br J Pharmacol; 1997 Aug; 121(8):1531-40. PubMed ID: 9283685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of N-ethylmaleimide on transmitter release from the skeletal neuromuscular junction of Bufo marinus.
    Knight D; Bellingham MC; Lavidis NA
    Synapse; 2004 Sep; 53(3):151-8. PubMed ID: 15236347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of calcium ions on bimodal parameters of mediator liberation in frog sartorius muscle neuromuscular junctions].
    Zefirov AL
    Fiziol Zh SSSR Im I M Sechenova; 1980 Apr; 66(4):531-6. PubMed ID: 6104608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states.
    Kim YI; Goldner MM; Sanders DB
    Muscle Nerve; 1980; 3(2):112-9. PubMed ID: 6245355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.
    Molgó J; Lemeignan M; Lechat P
    Eur J Pharmacol; 1979 Jan; 53(3):307-11. PubMed ID: 32061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of imidazole on neuromuscular transmission and on synaptosomal calcium uptake in the rat.
    Ribeiro JA; Dominguez ML; Sá-Aimeida AM; Gonçalves MJ
    Arch Int Pharmacodyn Ther; 1981 Jun; 251(2):270-84. PubMed ID: 6269509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 4-aminopyridine on neuromuscular transmission.
    Lundh H
    Brain Res; 1978 Sep; 153(2):307-18. PubMed ID: 210882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Aminopyridine does not increase m.e.p.p. frequencies at junctions depolarized by potassium.
    van der Kloot W; Madden KS
    Brain Res; 1981 Apr; 210(1-2):467-70. PubMed ID: 6971693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.